Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$9.95 - $12.27 $99 - $122
10 Added 0.53%
1,898 $20,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $9 - $15
-1 Reduced 0.05%
1,888 $21,000
Q4 2021

Feb 15, 2022

BUY
$12.09 - $14.68 $132 - $161
11 Added 0.59%
1,889 $26,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $1,881 - $2,148
-142 Reduced 7.03%
1,878 $25,000
Q2 2021

Aug 09, 2021

BUY
$12.97 - $16.15 $220 - $274
17 Added 0.85%
2,020 $28,000
Q1 2021

May 18, 2021

BUY
$13.59 - $18.54 $4,063 - $5,543
299 Added 17.55%
2,003 $28,000
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $24,367 - $31,932
1,704 New
1,704 $32,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.